Missing the obvious: psychosocial obstacles in Veterans with hepatocellular carcinoma  by Hwa, Kimberly J. et al.
ORIGINAL ARTICLE
Missing the obvious: psychosocial obstacles in Veterans with
hepatocellular carcinoma
Kimberly J. Hwa1, Monica M. Dua2, Sherry M. Wren1,2 & Brendan C. Visser1,2
1 Department of Surgery, Palo Alto Veterans Affairs, Palo Alto, CA, USA, and 2 Department of Surgery, Stanford University School of Medicine, Stanford,
CA, USA
Abstract
Background: Socioeconomic disparities in patients with hepatocellular carcinoma (HCC) influence
medical treatment. In addition to socioeconomic barriers, the Veteran population suffers from signifi-
cant psychosocial obstacles. This study identifies the social challenges that Veterans face while under-
going treatment for HCC.
Methods: One hundred Veterans at the Palo Alto VA treated for HCC from 2009 to 2014 (50 consecu-
tive patients who underwent a surgical procedure; 50 treated with intra-arterial therapy) were retro-
spectively reviewed.
Results: Substance abuse history was identified in 96%, and half were unemployed. Most patients
survived on a limited income [median $1340, interquartile range (IQR) 900–2125]; 36% on ≤ $1000/
month, 37% between $1001–2000/month and 27% with >$2000/month. A history of homelessness
was found in 30%, more common in those of the lowest income (57% of ≤$1K/month group, 23% of
$1–2K/month group and 9% of >$2K/month group, P < 0.01). Psychiatric illness was present in 64/100
patients; among these the majority received ongoing psychiatric treatment. Transportation was pro-
vided to 23% of patients who would otherwise have been unable to attend medical appointments.
Conclusions: Psychiatric disease and substance abuse are highly prevalent among Veterans with
HCC. Most patients survive on a very meager income. These profound socioeconomic and psycho-
social problems must be recognized when providing care for HCC to this population to provide ade-
quate treatment and surveillance.
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Introduction
The incidence of hepatocellular carcinoma (HCC) has doubled
over the last few decades primarily owing to the hepatitis
C virus (HCV) infection.1–6 An estimated 1.6% (4.1 million
people) of the US population have been exposed to HCV. The
rate of Veterans exposed to HCV is even higher at about three
times that of the general population with a range from 5.4%
to 51% in certain subgroups.5,7–11 In the past decade, data
from the VA HCV Clinical Case Registry have demonstrated
that the prevalence of cirrhosis and hepatic decompensation
has doubled, and the prevalence of HCC has increased by
19-fold in the Veteran population.12
In addition to this increased medical risk, Veterans have
profound psychosocial and socioeconomic barriers to health
care. Factors such as homelessness, low income, substance
abuse, psychiatric disorders and low socioeconomic status are
all highly prevalent in this population and have been shown to
affect negatively cancer care.2,13–24 These barriers seem to be
out of proportion and not well acknowledged in the Veteran
population.7,8,25
As cancer treatment continues to evolve, clinicians taking
care of Veterans not only need to consider the disease process
but should also be aware of the psychological and socioeco-
nomic issues these patients face. With respect to HCC, these
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issues are commonly evaluated when considering transplanta-
tion26; however, they are less often investigated when a patient
is being assessed for surgical resection and intra-arterial thera-
pies. The purpose of this study was to identify and quantify
psychosocial and economic challenges in a Veteran cohort
being treated for HCC.
Patients and methods
After obtaining Internal Review Board (IRB) approval, 100
HCC patients treated from 2009 to 2014 were retrospectively
reviewed. Fifty consecutive patients who underwent a surgical
procedure – resection or laparoscopic radiofrequency ablation
(RFA) – and 50 consecutive patients who were primarily trea-
ted with intra-arterial therapy (transarterial chemoembolization
or bland embolization) were selected. The diagnosis of HCC
was made via identification of classic imaging characteristics
on computed tomography (CT) and/or magnetic resonance
imaging (MRI) (hypervascular arterial phase with washout on
delayed phase and presence of pseudocapsule). If the patient
underwent a resection, confirmation of HCC was made after
specimen removal by pathology.
Patient information was obtained by chart review of the VA
electronic medical record – Computerized Patient Record Sys-
tem (CPRS), VistaWeb/Vista R01. Data on patient demograph-
ics, comorbidities, substance use, criminal history, income
level, psychiatric diagnosis, current employment and place of
residence were collected from progress notes by social work,
psychiatry, case management and surgery. Detailed information
regarding criminal history was typically only available when a
comprehensive history was being obtained for patients under-
going either (i) evaluation of treatment programmes for psy-
chiatric disorders, or (ii) a complete needs assessment by a
social work.
Standard descriptive statistics was performed for categorical
and continuous variables. Discrete categorical variables were
compared using Fisher’s exact test. Continuous variables were
expressed as median with interquartile range (IQR) or mean
with standard deviation and means were compared using Stu-
dent’s t-test. All tests were two-tailed, and statistical signifi-
cance was set at a P-value < 0.05. Kaplan–Meier estimations
were used to analyse overall survival. Statistical analyses were
performed using STATA version 13.1 (StataCorp, College
Station, TX, USA).
Results
Demographics
The median age of the cohort was 63 years (IQR 60–67).
Eighty-nine per cent of patients had cirrhosis with 79% of
patients testing positive for HCV. Of the comorbidities
reviewed, 66% had hypertension, 65% were obese [average
body mass index (BMI) 28.6  5.2], 33% had hyperlipidaemia,
28% osteoarthritis, 24% were diabetic, 17% had chronic
obstructive pulmonary disease (COPD) and 14% had coronary
artery disease.
Psychosocial history
Ninety-six per cent of patients had a history of substance abuse
with 89% having a history of alcohol abuse and 79% having a
history of drug use not including alcohol (marijuana, metham-
phetamines, cocaine, LSD, heroin or opioids). At initial presen-
tation, 24% were currently drinking alcohol and 21% were
actively using drugs. Twenty-eight per cent of patients sought
addiction treatment services through the VA. Smoking history
was present in 84% of patients with 41% actively smoking.
Social history characteristics are demonstrated in Table 1.
Sixty-four per cent of patients had a documented psychiatric
disorder. Of this group, 92% (59/64) were actively receiving
treatment through the VA. Depression and post-traumatic
stress disorder (PTSD) were the top two diagnoses, 56% (36/
64) and 34% (22/64), respectively.
Criminal History
Fifty-one per cent of patients had a documented criminal his-
tory. The majority of cases were for driving under the influ-
ence (DUI) followed by assault and battery, drunkenness in
public, theft, possession of or under the influence of illegal
substances and a sexual offense.
Income
Financial information was available for 84 out of the 100
patients. The median monthly income was $1340 (IQR $900–
$2125). Income was stratified into three subgroups indexed to
the Federal Poverty Level ($973/month, $11 770/year). Thirty-
six per cent fell at or below the Federal Poverty Level of
≤$1000/month, 37% between $1001 and 2000/month and 27%
had income >$2000/month (Table 2). Forty-eight per cent of
patients are supported through funds coming from the VA.
Thirty per cent of patients receive a VA pension (a fund for
patients with low or no income source); the maximum amount
for this pension is $12 000/year. Eighteen percent of patients
are on VA disability or a retirement fund. Seventy per cent of
Table 1 Social history characteristics of the total cohort
Variable All patients
n = 100 (%)
History of any substance abuse 96
History of alcohol abuse 89
Current alcohol abuse 24
History of drug use 79
Current drug use 21
History of smoking 85
Current smoking 41
Criminal history 51
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patients were receiving financial support from the state - either
social security disability insurance or supplemental security
income.
Employment history revealed that 54% of patients were
unemployed, 34% were retired, and only 12% were working.
Of the 12% of patients that were employed, six were working
full-time, five were working part-time, and it was unknown
whether the last patient was working full- or part-time.
Twenty-three per cent of patients required assistance with
travel. This included patients receiving reimbursement for
mileage, shuttle reservations, cab rides or air travel.
Homelessness
Housing information was available for 90 out of 100 patients
(Table 3). Only 23% of patients owned a home, and 26% were
currently renters. A history of homelessness was present in
30% of patients, which was more common in those with the
lowest income group: 57% (17/30) of ≤$1K/month group, 23%
(7/31) of $1–2K/month group and 9% (2/23) of >$2K/month
group (P < 0.01). A separate group of patients, comprising
22% (19/90) of the cohort, were documented as living with a
family member, friend or in a trailer. Housing assistance
through the VA was provided to 15% (13/90) of patients.
Survival
The median survival for the 42 patients that underwent a
resection was 46.1 months and for the 50 patients that under-
went transcatheter arterial chemoembolization (TACE) was
17.3 months. There were only eight patients that underwent a
laparoscopic RFA. For those patients that underwent a resec-
tion, 1-, 3- and 5-year survival rates are 80.3%, 62.4%, and
24.1%, respectively. The follow-up period for those patients
who underwent TACE or laparoscopic RFA was only extended
to 3 years. The 1- and 3-year survival rates for TACE were
56.7% and 31.4% and for RFA were 75% and 60% (Fig. 1).
Discussion
The present findings demonstrate many psychosocial and
socioeconomic factors in Veterans treated for HCC. These fac-
tors have all been identified to be barriers to successful medical
care delivery and, therefore, need to be identified and
addressed.2,13–24 Although patients in the general population
with HCC face similar barriers, these obstacles are much more
prevalent in the Veteran population. Few studies have quanti-
fied these variables to the degree of this data set. Comparison
of the general population to Veterans with HCC demonstrates
a higher prevalence of psychiatric disorders (19.6–50% versus
64%), smoking (13.6% versus 41%) and alcohol use (14.5%
versus 24%) in the Veterans (24,27–30). Veterans are also likely
to survive on an average lower income; however, a direct com-
parison is difficult to make with the general population given
the lack of reported financial income in these patients. Many
studies have consistently found that patients of lower socioeco-
nomic status have poorer survival outcomes after HCC treat-
ment.14,17,18,21,26
One-third of the cohort had a history of homelessness.
Homelessness is a prevalent issue in the Veteran population.24
Housing is a critical determinant of health, and there are a
significant number of Veterans who are homeless in the com-
munity. Multiple studies have found that homeless patients
have higher mortality rates,20,31–33 and in homeless Veterans,
mortality is three times higher when compared with Veterans
who are housed.16 Those patients with unstable housing situa-
tions have worse health conditions, psychiatric issues and more
chronic illnesses.16 Higher rates of substance abuse and emer-
gency care are also noted in homeless patients.34
The Veteran HCC patients also suffer from high rates of
smoking, substance abuse, and psychiatric illness. About 84%
of our study group had a history of smoking, and 41% of
patients were smoking at the time of surgical or procedural
treatment. Smoking not only impairs wound healing,35,36 it has
also been shown to contribute to poor compliance and non-
adherence to medical therapies.37 Psychiatric disorders have
also been shown to decrease adherence to medical therapies by
three-fold.38,39 In some studies, 89–93% of HCV-positive
patients had psychiatric and/or substance use disorders docu-
mented in their medical records.7,25 In our study, we found
96% of patients had a history of substance abuse and 64% of
patients had a documented psychiatric illness. Patients with
mental illness tend to have higher rates of mortality when lost
to follow-up care.13,40 However, outreach programmes by the
VA to re-engage these patients have been successful in reduc-
ing mortality when treatment is resumed.41
Transportation is also an overlooked, yet important aspect
of healthcare, which can often be a barrier to receiving
Table 2 Income stratified indexed to the Federal Poverty Level
Financial Level n = 84a
Income per month, median (IQR) $1340 ($900–2125)
<$1000/month, n (%) 30 (36)
$1001–2000/month, n (%) 31 (37)
>$2000/month, n (%) 23 (27)
aFinancial information available for 84 out of 100 patients.
Table 3 Housing characteristics
Housing n = 90a
Own, n (%) 21 (23)
Rent, n (%) 23 (26)
Homeless, n (%) 27 (30)
Other (trailer, truck, etc.), n (%) 19 (21)
aHousing information available for 90 out of 100 patients.
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treatment.27,42,43 In this study, 23% of patients received travel
assistance. In a recent review, 10–51% of patients reported trans-
portation as a barrier to health care access, most often owing to
not owning or lack of access to a car.27,42,43 Patients with a lower
socioeconomic status also had higher rates of transportation bar-
riers to ongoing health care compared with patients in the higher
socioeconomic status group. The number of patients receiving
travel assistance through the VA in this population of patients is
quite low, suggesting that VA-implemented travel assistance
helps to minimize transportation as a barrier. The VA is
uniquely equipped to dedicate non-income based resources to
facilitate access for Veteran patients to get their medical care.
There is often lodging available for family members to stay on
campus while loved ones are receiving treatment. Case managers
can arrange for shuttles, vanpools and occasionally cab rides. For
patients who have their own vehicles but travel long distances,
there is a mileage reimbursement programme. Homeless patients
discharged from the hospital have arrangements made by case
managers or social workers for appropriate shelter during the
post-operative recovery periods. Those meeting criteria are
enrolled in the Housing and Urban Development - Veterans
Affairs Supportive Housing program that assists Veterans in
finding permanent housing.
A limitation of this report is that it is a single centre retro-
spective study, only catching the population of Veterans with
HCC being treated at the Palo Alto VA. We cannot capture
those patients who have not come to treatment owing to barri-
ers to care, loss of follow-up, or failure of HCC screening.
Another limitation of this Veterans HCC patient population is
that we did not explicitly include those patients that were eval-
uated for transplantation through the gastroenterology clinic
(who were likely to have fewer troubles than the cohort
described here). All patients are discussed at a multidisciplinary
tumour board; the decision regarding treatment modality
(primary resection or referral for transplantation) is made
jointly. However, that decision does itself reflect psychosocial
comorbidities – patients with clear psychosocial contraindica-
tions to transplantation are triaged to resection. Therefore, the
patients that underwent surgery are likely to have more psy-
chosocial problems than those considered for transplantation
(although many of these patients would have been captured
because of the use of arterial therapy as a bridge toward trans-
plantation). In future investigations, we plan to investigate
how many patients among all Veterans with HCC have disease
within transplantation criteria but are excluded only because of
psychosocial comorbidities. Finally, in the present study, there
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is no direct comparison group of non-veteran HCC patients to
assess differences in socioeconomic and psychosocial hardships.
Although this study specifically examined barriers such as
homelessness, income, substance abuse and psychiatric illness in
a Veteran population with HCC, these same factors influence
medical care in all disciplines, lending their importance to gen-
eral health practice. There is an abundance of literature on how
socioeconomic status affects medical care and treatment, hospi-
tal readmissions and length of stay in patients with cardiovascu-
lar disease, diabetes and other types of cancer.44–48 The Veteran
population represents a socioeconomically deprived group of
patients; however, patients with similar obstacles exist in all
health care systems. Within hepatobiliary practice, this study also
adds understanding to the psychosocial problems of HCC
patients associated with HCV and IV drug injection populations
that similarly exist elsewhere. It is necessary to identify and
address these issues to successfully deliver medical care and
maintain appropriate compliance with treatment.
In conclusion, the majority of Veterans treated for HCC have
substantial socioeconomic and psychosocial issues, as well as
extreme economic hardship with many of them surviving on
very meager income. It is a true testament to the success of the
VA system in providing access and support that this cohort
received treatment for their HCC given their profound psy-
chosocial troubles. These issues must be recognized and proac-
tively addressed when providing care to this patient population.
Veteran patients require substantial non-medical resources to
complete treatment and continue adequate HCC surveillance.
Early involvement of social work and other support resources
can help facilitate optimal treatment for these patients.
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